NYPD Commissioner Raymond Kelly sketches out GPS tracking decoys for controlled substances
According to an NYTimes article this week, pharmacies in New York City and surrounding areas are, or will soon be, deploying decoy bottles of oyxcodone, a controlled substance, with GPS tracking sensors embedded. In theory, a thief stealing the drug could be tracked by police monitoring the GPS signals. The decoy bottles come from Purdue Pharma, makers of Oxycontin and other controlled-substance formulations, according to the article; a Purdue spokeswoman confirmed that the company is working with police in New York and commented that “it would not be appropriate” to disclose details.
Nevertheless, Kelly and other NYPD spokespersons detailed that the devices are in “bait bottles,” not containing drug, and the GPS tracker is activated when the bottle is removed from a base plate on the pharmacy shelf. The technology is being tried in Suffolk County, New York, which witnessed a brutal robber y and multiple homicides in 2011, part of a rash of such robberies.
Purdue, whose controlled-release OxyContin product has long been a preferred abused drug, was one of the early adopters of RFID technology to serialize product bottles in the mid-2000s, and has supported numerous law-enforcement and public-health efforts to counter drug abuse.
The article concludes with the reporter saying that the NYPD is considering the “somewhat fanciful” idea of tracking not just bottles, but individual pills. But readers of Pharmaceutical Commerce know that this is hardly fanciful: technologies like those of NanoGuardian, TruTag Technologies or Applied DNA Sciences have all proposed methods to identify individual tablets with markings or taggants.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.